Research focus: ‘Health not height’ – Trial results for a targeted treatment for children with achondroplasia

2019-09-16T12:05:22+00:00August 1st, 2019|Growth disorders, Podcast|

Professor Ravi Savarirayan talks through the recently published results in The New England Journal of Medicine for the C-type natriuretic peptide analogue vosiritide in children with achondroplasia.